telmisartan + clonidine

Telmisartan + clonidine is a fixed-dose combination of two antihypertensive agents: **telmisartan**, an angiotensin II receptor blocker (ARB), and **clonidine**, an alpha-2 adrenergic receptor agonist. Telmisartan blocks the angiotensin II type 1 (AT1) receptor, thereby inhibiting the renin-angiotensin-aldosterone system, resulting in vasodilation and reduced blood pressure. Clonidine acts centrally at the alpha-2 adrenergic receptors in the brainstem to decrease sympathetic outflow, leading to reduced peripheral vascular resistance and blood pressure. This combination is used for the management of hypertension, particularly in cases where monotherapy is inadequate. The combination aims to achieve additive or synergistic blood pressure reduction due to their complementary mechanisms of action. While combination products containing telmisartan and other antihypertensive agents (such as amlodipine or hydrochlorothiazide) are marketed, the specific combination of telmisartan + clonidine is less common and may be found in certain markets or in custom compounded formulations.